Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency

Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Researchers Hannah Kinoshita
et al. described the clinical course, antibody, and T cell responses to SARS-CoV-2 structural proteins in a cohort of adult and pediatric patients with antibody deficiencies (related and unrelated) and infected with SARS-CoV-2. The researchers at Children's National Hospital are the first to demonstrate this response for immunocompromised patients. Their findings are published in the

Related Keywords

Michael Keller ,Hannah Kinoshita ,Ramya Dwivedi ,Children National ,Children National Hospital ,Program For Cell Enhancement ,Translational Research Laboratory ,National Hospital ,Robust Antibody ,Image Credit ,Cell Enhancement ,Cell ,Immune Response ,Mmunodeficiency ,Cars ,Ars Cov 2 ,Ntibody ,Children ,Coronavirus ,Coronavirus Disease Covid 19 ,Hospital ,Mmunology ,Immunotherapy ,Ortality ,Protein ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spike Protein ,Yndrome ,T Cell ,மைக்கேல் கெல்லரர் ,ரம்யா டுவிவேடி ,குழந்தைகள் தேசிய ,குழந்தைகள் தேசிய மருத்துவமனை ,ப்ரோக்ர்யாம் க்கு செல் விரிவாக்கம் ,மொழிபெயர்ப்பு ஆராய்ச்சி ஆய்வகம் ,தேசிய மருத்துவமனை ,படம் கடன் ,செல் விரிவாக்கம் ,செல் ,அரசு ,டி செல் ,